United States · FDA National Drug Code directory
Etoposide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-3266_a591eea6-af04-4207-b0f7-61fbada4719c
- Product NDC
- 0378-3266
- Form
- CAPSULE
- Composition / generic term
- etoposide
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20011022
- Source listing expiry
- 20261231
Source-listed ingredients
- ETOPOSIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 CAPSULE in 1 CARTON (0378-3266-94) · 0378-3266-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →